Endocrine Metabolic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC46-7

DiraChart Clinical Reference
Protected section 7 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 7 of 25PreviousNext

5. Abnormal findings

Abnormal findings are charted as a chain — finding, severity, comparison to the individualized target or baseline, the risk it creates, and the skilled action taken.

  • A glucose value or pattern below the individualized target with symptoms — hypoglycemia, severe if accompanied by confusion, seizure, or unresponsiveness.
  • A glucose pattern persistently above the individualized target, or a regimen no longer controlling glucose — hyperglycemia requiring regimen review.
  • Very high glucose with dehydration, Kussmaul respirations or fruity breath, and mental-status change — concerning for diabetic ketoacidosis or hyperosmolar hyperglycemic state.
  • Hypotension, profound weakness, and mental-status change in a steroid-dependent patient or after abrupt steroid cessation — concerning for adrenal crisis.
  • A new foot lesion or loss of protective sensation — high-risk for limb loss (route to Wounds and Touch/Sensation).
  • High fever with tachycardia or atrial fibrillation, agitation, and confusion in a hyperthyroid patient, or hypothermia with bradycardia and obtundation in a hypothyroid patient — concerning for thyroid storm or myxedema (route to Neck/Thyroid).
  • Incorrect insulin technique, dosing errors, or a lapse in monitoring — a safety risk requiring re-teaching and possibly notification.
  • Laboratory trends indicating worsening glycemic control, an electrolyte disturbance, or declining renal function — requiring provider collaboration.
Section NavigationPart 7 of 25PreviousNext